Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 6, 2016, Pages 962-968

  Sheng, Zi Ke ^a,b,c   Wang, Weixia ^a,b,d   Guo, Qinglan ^a,b   Xu, Xiaogang ^a,b   Wang, Minghua ^a,b   Yang, Yang ^a,b   Wang, Minggui ^a,b,d  

^a FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

carbapenem resistance; Klebsiella pneumoniae; risk factors; tigecycline resistance

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE KPC 2; CARBAPENEM; CARBAPENEMASE; CEFEPIME; COLISTIN; FOSFOMYCIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; RNA METHYLTRANSFERASE; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; CARBAPENEM DERIVATIVE; METHYLTRANSFERASE; MINOCYCLINE; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EXPOSURE; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; ADULT; AGED; ANALOGS AND DERIVATIVES; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; FEMALE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84949643298     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2015.10.014     Document Type: Article

References (22)

1. 1 Castanheira, M., Sader, H.S., Jones, R.N., Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. Microb Drug Resist 16 (2010), 61–65.
2. 2 Roy, S., Datta, S., Viswanathan, R., Singh, A.K., Basu, S., Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007–10) and role of an efflux pump in tigecycline non-susceptibility. J Antimicrob Chemother 68 (2013), 1036–1042.
3. 3 Denys, G.A., Callister, S.M., Dowzicky, M.J., Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). Ann Clin Microbiol Antimicrob, 12, 2013, 24.
4. 4 Rodriguez-Avial, C., Rodriguez-Avial, I., Merino, P., Picazo, J.J., Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect 18 (2012), 61–66.
5. 5 Neonakis, I.K., Stylianou, K., Daphnis, E., Maraki, S., First case of resistance to tigecycline by Klebsiella pneumoniae in a European university hospital. Indian J Med Microbiol 29 (2011), 78–79.
6. 6 Tsai, H.Y., Liao, C.H., Cheng, A., Liu, C.Y., Huang, Y.T., Sheng, W.H., et al. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli. J Infect 65 (2012), 584–586.
7. 7 Spanu, T., De Angelis, G., Cipriani, M., Pedruzzi, B., D'Inzeo, T., Cataldo, M.A., et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 56 (2012), 4516–4518.
8. 8 Sheng, Z.K., Hu, F., Wang, W., Guo, Q., Chen, Z., Xu, X., et al. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 58 (2014), 6982–6985.
9. 9 Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. CLSI document M07–A9, 2012, CLSI, Wayne, PA.
10. KPC and rmtB on a single plasmid in Enterobacter amnigenus and Klebsiella pneumoniae isolates from the same patient. Eur J Clin Microbiol Infect Dis 31 (2012), 1585–1591.
11. 11 Poirel, L., Walsh, T.R., Cuvillier, V., Nordmann, P., Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70 (2011), 119–123.
12. 12 Li, J.J., Sheng, Z.K., Deng, M., Bi, S., Hu, F.S., Miao, H.F., et al. Epidemic of Klebsiella pneumoniae ST11 clone coproducing KPC-2 and 16S rRNA methylase RmtB in a Chinese university hospital. BMC Infect Dis, 12, 2012, 373.
13. 13 Wohlwend, N., Endimiani, A., Francey, T., Perreten, V., Third generation-cephalosporin-resistant Klebsiella pneumoniae isolates from humans and companion animals in Switzerland: spread of a DHA-producing ST11 clone in the veterinary setting. Antimicrob Agents Chemother 59 (2015), 2949–2955.
14. 14 Nigo, M., Cevallos, C.S., Woods, K., Flores, V.M., Francis, G., Perlman, D.C., et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 57 (2013), 5743–5746.
15. 15 Lin, Y.T., Wang, F.D., Chan, Y.J., Fu, Y.C., Fung, C.P., Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan. BMC Infect Dis, 14, 2014, 1.
16. 16 Zhong, X., Xu, H., Chen, D., Zhou, H., Hu, X., Cheng, G., First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PloS One, 9, 2014, e115185.
17. 17 Li, H., Zhang, J., Liu, Y., Zheng, R., Chen, H., Wang, X., et al. Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. Diagn Microbiol Infect Dis 78 (2014), 63–65.
18. 18 Pereira, P.S., de Araujo, C.F., Seki, L.M., Zahner, V., Carvalho-Assef, A.P., Asensi, M.D., Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 68 (2013), 312–316.
19. KPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66 (2011), 1510–1513.
20. 20 Saito, R., Takahashi, R., Sawabe, E., Koyano, S., Takahashi, Y., Shima, M., et al. First report of KPC-2 carbapenamase-producing Klebsiella pneumoniae in Japan. Antimicrob Agents Chemother 58 (2014), 2961–2963.
21. KPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol 50 (2012), 475–476.
22. 22 Tacconelli, E., Cataldo, M.A., Dancer, S.J., De Angelis, G., Falcone, M., Frank, U., et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20 (2014), 1–55.